Skip to content

Clinical trials

Multiple Sclerosis trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Country / region: Czechia Clear all

123 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20043
20065
200711
20088
20097
20105
20116
20126
201311
20143
20152
20165
20177
20185
20194
20204
202110
20223
20236
20243
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed81
Terminated17
Unknown status8
Active, not recruiting7
Recruiting6
Not yet recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen25
Novartis Pharmaceuticals12
Sanofi9
Bayer7
Charles University, Czech Republic6
Actelion5
Jazz Pharmaceuticals4
Merck KGaA, Darmstadt, Germany4
University Hospital Ostrava4
Genzyme, a Sanofi Company3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis123
Multiple Sclerosis, Relapsing-Remitting28
Recurrence9
Muscle Spasticity6
Multiple Sclerosis, Chronic Progressive5
Fatigue4
Autoimmune Diseases2
Disease Progression2
Lower Urinary Tract Symptoms2
Urinary Bladder, Neurogenic2

Trials

Showing 26 to 50 of 123. Each trial links to its page on Pharma Observatory.

23 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.